286 filings
8-K
AIM
AIM ImmunoTech Inc
20 Feb 24
Entry into a Material Definitive Agreement
4:31pm
8-K
AIM
AIM ImmunoTech Inc
9 Feb 24
AIM ImmunoTech Reports Positive Topline Results from Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions
3:47pm
8-K
AIM
AIM ImmunoTech Inc
25 Jan 24
Regulation FD Disclosure
5:00pm
8-K
AIM
AIM ImmunoTech Inc
10 Jan 24
Submission of Matters to a Vote of Security Holders
1:42pm
8-K
AIM
AIM ImmunoTech Inc
10 Jan 24
AIM ImmunoTech Announces Open Enrollment for Phase 1b/2 Study Evaluating
8:45am
8-K
sqejm2is9uijei
15 Nov 23
Regulation FD Disclosure
7:30am
8-K
i06r26rmb
8 Nov 23
Regulation FD Disclosure
8:45am
8-K
cvtbwrd7
29 Sep 23
Entry into a Material Definitive Agreement
7:00am
8-K
gnauwieej0qg1np
22 Sep 23
Regulation FD Disclosure
9:10am
8-K
u2y2x46bdi30scl
23 Aug 23
Regulation FD Disclosure
8:51am
8-K
qierr57k1npra
15 Aug 23
Regulation FD Disclosure
7:00am
8-K
c9czi 84f
10 Jul 23
Regulation FD Disclosure
4:45pm
8-K
vz62a4qvm7qs0liln3rr
27 Jun 23
Regulation FD Disclosure
2:00pm
8-K
9tjvw 5wl6xv6lh54
30 May 23
Entry into a Material Definitive Agreement
7:00am
8-K
y72r8wuxgazzfld6
19 Apr 23
Entry into a Material Definitive Agreement
4:45pm
8-K
ay14i8
7 Apr 23
Entry into a Material Definitive Agreement
4:00pm
8-K
vxsfrsp88g
30 Mar 23
Departure of Directors or Certain Officers
8:50am
8-K
g0jt0iea
16 Mar 23
AIM ImmunoTech Announces Late-Breaking Presentation at the International
8:50am
8-K
rxs3eh9qsda
13 Mar 23
Regulation FD Disclosure
8:30am
8-K
uyucjtju f7yr639
8 Mar 23
Regulation FD Disclosure
8:50am